Replimune Group (REPL) Institutional Ownership

92.53% of Replimune Group's stock is owned by institutional investors. Learn more on REPL's institutional investor holdings.

Of the 168 institutional investors that purchased Replimune Group's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($8.96M), Braidwell LP ($4.38M), Readystate Asset Management LP ($2.73M), Balyasny Asset Management L.P. ($2.29M), Erste Asset Management GmbH ($2.12M), State Street Corp ($1.95M), and Adage Capital Partners GP L.L.C. ($1.81M).

Institutional investors have bought a total of 36,733,041 shares in the last 24 months. This purchase volume represents approximately $308.77M in transactions.

Of the 42 institutional investors that sold Replimune Group's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Balyasny Asset Management L.P. ($2.60M), Fcpm Iii Services B.V. ($1.35M), Boxer Capital Management LLC ($1.16M), Deutsche Bank AG ($485.62K), Goldman Sachs Group Inc. ($476.66K), Bank of America Corp DE ($395.83K), and Diadema Partners LP ($381.30K).

Institutional investors have sold a total of 9,133,347 shares in the last 24 months. This volume of shares sold represents approximately $77.08M in transactions.